MDM2 SNP309 and p53 Codon 72 Genetic Polymorphisms and Risk of AML: An Egyptian Study

被引：0
|
作者：
ZainabElsaadany [1 ]
El-Danasouri, Nabil [1 ]
Nabil, Safa [2 ]
机构：
[1] Cairo Univ, Giza, Egypt
[2] Natl Res Ctr, Cairo, Egypt
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2019年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-040
引用
收藏
页码：S27 / S27
页数：1
相关论文
共 50 条
  • [31] MDM2 SNP309 and risk of endometrial cancer
    Knappskog, Stian
    Lonning, Per Eystein
    POLISH JOURNAL OF PATHOLOGY, 2013, 64 (01) : 69 - 70
  • [32] MDM2 SNP309 and risk of cervical cancer
    Knappskog, Stian
    Lonning, Per Eystein
    TUMOR BIOLOGY, 2014, 35 (07) : 6185 - 6186
  • [33] Assessment of TP53 Polymorphisms and MDM2 SNP309 in Premenopausal Breast Cancer Risk
    Samuel, Nardin
    Id Said, Badr
    Guha, Tanya
    Novokmet, Ana
    Li, Weili
    Silwal-Pandit, Laxmi
    Borrsen-Dale, Anne-Lise
    Langerod, Anita
    Hudson, Thomas J.
    Malkin, David
    HUMAN MUTATION, 2017, 38 (03) : 265 - 268
  • [34] Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Kato, Akihisa
    Ohara, Hirotaka
    Inagaki, Hiroshi
    Joh, Takashi
    PLOS ONE, 2015, 10 (03):
  • [35] Impact of TP53 Codon 72 and MDM2 SNP 309 Polymorphisms in Pancreatic Ductal Adenocarcinoma
    Hori, Yasuki
    Miyabe, Katsuyuki
    Yoshida, Michihiro
    Nakazawa, Takahiro
    Hayashi, Kazuki
    Naitoh, Itaru
    Shimizu, Shuya
    Kondo, Hiromu
    Nishi, Yuji
    Umemura, Shuichiro
    Kato, Akihisa
    Joh, Takashi
    GASTROENTEROLOGY, 2015, 148 (04) : S392 - S392
  • [36] MDM2 SNP309 and P53 Pro72Arg polymorphisms and breast cancer risk in a chemoprevention trial involving premenopausal women at risk for breast cancer
    Johansson, Harriet
    Fronza, Gilberto
    Perfumo, Chiara
    Gandini, Sara
    Guerrieri-Gonzaga, Aliana
    Macis, Debora
    Davide, Serrano
    Lazzeroni, Matteo
    Cazzaniga, Massimiliano
    Gulisano, Marcella
    Decensi, Andrea
    Bonanni, Bernardo
    CANCER RESEARCH, 2009, 69
  • [37] Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma
    Qiu, Moqin
    Liu, Yingchun
    Yu, Xiangyuan
    Qin, Linyuan
    Bei, Chunhua
    Zeng, Xiaoyun
    Qiu, Xiaoqiang
    Tang, Bo
    He, Songqing
    Yu, Hongping
    TUMOR BIOLOGY, 2016, 37 (03) : 3863 - 3870
  • [38] MDM2 SNP309 and TP53 SNPArg72Pro Polymorphisms in Myelodysplastic Syndrome.
    Machado Neto, Joao Agostinho
    Traina, Fabiola
    Campos, Paula Melo
    Andreoli, Marilisia
    Metze, Irene Lorand
    Costa, Fernando Ferreira
    Saad, Sara T. O.
    BLOOD, 2009, 114 (22) : 693 - 694
  • [39] Association of rheumatoid arthritis with Mdm2 SNP309 and genetic evidence for an allele-specific interaction between MDM2 and p53 P72R variants: a case control study
    Assmann, G.
    Voswinkel, J.
    Mueller, M.
    Bittenbring, J.
    Koenig, J.
    Menzel, A.
    Pfreundschuh, M.
    Roemer, K.
    Melchers, I.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (04) : 615 - 619
  • [40] MDM2 SNP309 Confers Risk of Hereditary Melanoma
    Thunell, L. K.
    Bivik, C.
    Waster, P.
    Fredrikson, M.
    Stjernstrom, A.
    Synnerstad, I.
    Rosdahl, I.
    Enerback, C.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S277 - S277
12345